Changes in measured endometrial thickness predict in vitro fertilization success
|
|
- Jessica Lee
- 6 years ago
- Views:
Transcription
1 Changes in measured endometrial thickness predict in vitro fertilization success Grant D. E. McWilliams, D.O., a and John L. Frattarelli, M.D. b a Tripler Army Medical Center, Honolulu, Hawaii; and b Reproductive Medicine Associates of New Jersey, Somerset, New Jersey Objective: To assess the predictive ability of endometrial thickness and changes in endometrial thickness on pregnancy outcomes in patients undergoing IVF. Design: Retrospective cohort analysis. Setting: Academic IVF center. Patient(s): Infertile patients undergoing 132 fresh autologous IVF cycles. Intervention(s): Transvaginal ultrasound to assess endometrial thickness at three defined points during IVF (after pituitary suppression, on the sixth day of gonadotropin stimulation, and on the day of hcg administration). Main Outcome Measure(s): Primary outcome variables included endometrial lining thickness at baseline, on day 6 of gonadotropins, the day of hcg administration, and the change in endometrial thickness during gonadotropin stimulation. Result(s): Patients attaining pregnancy had significantly greater endometrial thickness on day 6 and endometrial thickness on day of hcg administration. Pregnant patients had a greater change in endometrial thickness from the baseline to day 6 when compared to nonpregnant patients. Threshold analysis and receiver operator characteristic curves noted significant endometrial thickness levels for implantation and pregnancy rates. Conclusion(s): Endometrial responsiveness and thickness during the early IVF stimulation seem to be better prognostic predictors of success than endometrial thickness at the start or the end of the IVF cycle. (Fertil Steril 2007;88: by American Society for Reproductive Medicine.) Key Words: Infertility, endometrial thickness, endometrial growth, transvaginal ultrasound, pregnancy outcome, IVF, endometrium, implantation Many factors contribute to obtaining a successful pregnancy. Understanding these factors can help in counseling patients regarding their chances of success and in offering interventions for improvement. Factors of both embryologic development and endometrial differentiation have been evaluated (1 15). With respect to endometrial differentiation, the possible predictors of pregnancy that have been evaluated are endometrial blood flow, endometrial pattern, and endometrial thickness (3 15). Endometrial thickness has been evaluated as a possible predictor of pregnancy in multiple studies with conflicting results (6, 11 16). Some studies have shown no differences in pregnancy rates with respect to endometrial thickness (6, 12). Rinaldi et al. (13) noted decreased pregnancy success with thin endometrial linings ( 10 mm) on the day of hcg administration (13). Others have found contrasting data in evaluating thicker endometrial linings on the day of hcg administration (12, 15). Received April 9, 2006; revised and accepted November 17, This study was supported by the Department of Clinical Investigation at Tripler Army Medical Center, Honolulu, HI. The views expressed in this manuscript are those of the investigators, and do not reflect the official policy or position of the Department of the Army, Department of Defense, or the U. S. Government. Reprint requests: John L. Frattarelli, M.D, Reproductive Medicine Associates of New Jersey, 100 Franklin Square Drive, Suite 200, Somerset NJ (FAX: , jfrattarelli@rmanj.com). Few studies have evaluated the change in endometrial thickness occurring during IVF stimulation (8, 11, 16). Based on the lack of available literature, this study was designed to assess the change in endometrial thickness throughout the IVF stimulation in patients undergoing IVF. MATERIALS AND METHODS Population This is a retrospective cohort analysis of 132 couples undergoing 132 fresh autologous IVF cycles at the Tripler Army Medical Center In Vitro Fertilization Institute. Institutional review board approval was obtained from the Tripler Army Medical Center institutional review board, Honolulu, HI. All infertile women undergoing IVF were eligible to participate in the study. Inclusion criteria included: normal basal FSH concentration per our laboratory ( 12 miu/ml), documented measurement of endometrial thickness at cycle baseline, on day 6 of gonadotropin stimulation, and on the day of human menopausal gonadotropin (hcg) administration. Patients were included independent of their diagnoses or reproductive history. Diminished ovarian reserve was defined as women having an FSH 10 miu/ml, basal antral follicle count of 4, or age 40 years. Exclusion criteria included: patients who did not have the transvaginal ultrasound on the specified dates, patients Fertility and Sterility Vol. 88, No. 1, July /07/$32.00 Copyright 2007 American Society for Reproductive Medicine, Published by Elsevier Inc. doi: /j.fertnstert
2 years, and patients without documented endometrial lining thickness. All endometrial measurements were performed by the author (JLF) using an ATL Ultramark HDI 3000 (Philips Medical Systems, Bothell, WA) with a 7-MHz vaginal transducer. The full thickness of the endometrial stripe was measured from the outer margin to the outer margin of the stripe. The stripe measurement was obtained approximately 1 cm from the fundus of the uterus. Experimental Design All patients started oral contraceptive pills (OCs) (30 g ethinyl estradiol, 0.15 mg norgestrel) the evening of menstrual day 3. The patients continued the OCs for 21 days before pituitary suppression with GnRH-a (500 g) (Luprolide acetate, Lupron; TAP Pharmaceuticals, North Chicago, IL). There was a 7-day overlap of the GnRH-a with the OCs. After 14 days of GnRH-a, the dose was decreased to 250 g, and stimulation with exogenous gonadotropins was initiated 5 days later. Baseline endometrial stripe measurement was determined on the day the patient decreased the GnRH-a dose to 250 g. When the largest cohort of follicles reached the 16 mm to 18 mm range, a single 10,000 IU intramuscular dose of hcg was administered. Transvaginal follicular aspiration was performed approximately 35 hours after hcg administration. Using a Wallace transfer catheter (Cooper Surgical, Shelton, CT), embryos were transferred under transabdominal ultrasound guidance 72 to 120 hours after follicular aspiration. Outcome Measures Primary outcome measures [1] were endometrial lining thickness on the baseline day after pituitary suppression with GnRH-a and 5 days before gonadotropin initiation (EMT Baseline ), [2] on day 6 of gonadotropin stimulation (EMT Day 6 ), [3] on the day of hcg administration (EMT hcg ), [4] the change in endometrial thickness from the EMT Baseline to EMT Day 6 ( EMT Day 6 Baseline ), [5] the change in endometrial thickness from the EMT Day 6 to EMT hcg ( EMT hcg - Day 6 ), and [6] the change in endometrial thickness from the EMT Baseline to EMT hcg ( EMT hcg - Baseline ). Secondary outcome measures were age, body mass index, IVF stimulation parameters (day 3 FSH, day 3 LH, day 3 estradiol, total ovarian volume, total antral follicle count, baseline estradiol, stimulation day 6 estradiol, day of hcg estradiol, total oocytes retrieved, total embryos obtained, ampules of gonadotropins used, and days of stimulation), and pregnancy outcomes (implantation rate, initial pregnancy rate, spontaneous pregnancy loss rate, and live birth rate). Pregnancies and the accompanying rates were defined as follows. Initial pregnancy was documented by a rising serum hcg concentration on luteal days 14 and 16. Spontaneous pregnancy loss was defined as a pregnancy loss following sonographic visualization of an intrauterine gestational sac at 5 to 6 weeks of gestation. Live birth rate was defined as those pregnancies proceeding to deliver a live infant. Implantation rate was calculated by dividing the number of gestational sacs visualized on transvaginal ultrasound by the number of embryos transferred. Statistical Analysis Statistical analysis was performed using SPSS 12.0 (SPSS Inc., Chicago, IL). For normally distributed data, a t test was used to compare the means between two groups, and a one-way analysis of variance was used to compare the means between multiple groups. For data not normally distributed, a Mann- Whitney rank sum test was used to compare means between two groups and a Kruskal-Wallis one-way analysis of variance on ranks was used to compare the means of multiple groups. A Tukey test was used for pairwise multiple comparisons. Patients were grouped by EMT Baseline, EMT Day 6, and EMT hcg at increments of 1 mm from 2 mmto 10 mm. Patients were then grouped by EMT Day 6 Baseline, EMT hcg - Baseline, and EMT hcg - Day 6 at increments of 1 mm from 4 mmto 10 mm. Implantation rates, pregnancy rates, pregnancy loss rates, and live birth rates were calculated for each increment. The rates above and below each threshold were evaluated to determine if there were any obvious break points at which there was a significant change in these rates. Contingency table analysis and receiver operator characteristic (ROC) curves were then used to evaluate the outcome rates above and below the selected threshold value. Differences in outcome rates were analyzed using a chi-square or two-tailed Fisher exact test where appropriate. Univariate analysis included regression and correlation coefficients examining the association of endometrial lining measurements and changes with parameters of ovarian reserve and response. An alpha error of 0.05 was considered significant for all comparisons. Relative risk and 95% confidence intervals are displayed where appropriate. All data were reported as means with their associated standard deviations. RESULTS A total of 132 IVF cycles were analyzed. The patient demographics, prestimulation, and stimulation parameters are depicted in Table 1. When subdividing the patients into those who conceived (n 70) and those who did not conceive (n 62), there were expected significant differences between these two groups with regard to age, total number of antral follicles, peak estradiol level on day of hcg administration, number of oocytes obtained, and total number of embryos. EMT measurements from the subgroup of pregnant patients were compared to the nonpregnant patients (Table 2). The pregnant patients had significantly thicker endometrial linings on EMT Day 6,onEMT hcg, and a greater change with EMT Day 6 Baseline. The overall change in endometrial Fertility and Sterility 75
3 TABLE 1 Population demographics, prestimulation, and stimulation parameters for the IVF study group, which was further subdivided into patients who conceived and patients who did not conceive. Variables All patients N 132 Pregnant N 70 Not pregnant N 62 a P value Age (years) b BMI (kg/m 2 ) b Day 3 FSH (miu/ml) c Day 3 LH (miu/ml) b Day 3 estradiol (pg/ml) b Total ovarian volume (cm 3 ) c Total antral follicles b Baseline estradiol (pg/ml) b Day 6 estradiol (pg/ml) b Day of hcg estradiol (pg/ml) b Number of oocytes retrieved b Number of embryos b Ampules of gonadotropins used b Days of stimulation b Note: Values represent means and the associated standard deviation. BMI body mass index. a Comparing pregnant patients with those not pregnant, P.05 is considered statistically significant. b Normality test failed. Mann-Whitney Rank Sum Test was used to determine significance. c Normality test passed. t Test was used to determine significance. thickness, EMT hcg Baseline, trended toward significance (P.05). Our patients had the following primary etiologies for their infertility: male factor (28%), anovulation (23%), tubal factor (19%), unknown (14%), diminished ovarian reserve (10%), and endometriosis (6%). Etiologies of infertility were compared to the endometrial stripe measurements in Table 3. Patients with the diagnosis of diminished ovarian reserve had the thinnest endometrium on EMT Day 6 and on EMT hcg, as well as the least amount of overall change from EMT hcg Baseline. Patients with the diagnosis of either endometriosis or male factor had the thickest endometrium on EMT hcg. Patients with the diagnosis of male factor had the greatest change from EMT hcg Baseline. TABLE 2 Pregnant patients compared to nonpregnant patients with respect to their endometrial thickness and the change in the endometrial thickness during the IVF cycle. Measurements Pregnant (n 70) Not Pregnant (n 62) a P value EMT Baseline (mm) b EMT Day 6 (mm) c EMT hcg (mm) b EMT Day 6 Baseline (mm) c EMT hcg Day 6 (mm) c EMT hcg Baseline (mm) c Note: Values represent means and the associated standard deviation. a P.05 is considered statistically significant. The pregnant patients were compared with those who were not pregnant. b Normality test failed. Mann-Whitney rank sum test was used to determine significance. c Normality test passed. t Test was used to determine significance. 76 McWilliams and Frattarelli Endometrial thickness and IVF success Vol. 88, No. 1, July 2007
4 TABLE 3 Etiologies for infertility compared to endometrial thickness (EMT) and change in endometrial thickness ( EMT). Anovulation DOR Endometriosis Male factor Tubal factor Unexplained a P value EMT Baseline (mm) b EMT Day 6 (mm) d e d d d d.05 c EMT hcg (mm) d e f f d d.001 c EMT Day 6 Baseline b (mm) EMT hcg Day c (mm) EMT hcg Baseline (mm) d e d f d d.05 c Note: DOR diminished ovarian reserve. a P.05 is considered statistically significant. b Normality test failed. Kruskal-Wallis one-way analysis of variance on ranks was used to determine significance. c Normality test passed. One-way analysis of variance was used to determine significance. d,e,f Values with different superscripts are statistically different based on pair-wise multiple comparison with a Tukey test. Univariate analyses were completed comparing endometrial thickness to the demographics, prestimulation, and stimulation parameters were performed. As expected, EMT and EMT measurements significantly correlated with each other. The EMT Baseline significantly correlated with the patient s level of estradiol on day 3 (r 0.38, P.001). The EMT Day 6 significantly correlated with most of the parameters including age (r 0.26, P.05), the level of FSH on day3(r 0.22, P.05), the total ovarian volume (r 0.27, P.05), the total number of antrals (r 0.30, P.05), the level of estradiol at baseline (r 0.19, P.05), the level of estradiol on day 6 of gonadotropin stimulation (r 0.45, P.001), the level of estradiol on day of hcg administration (r 0.45, P.001), the number of oocytes (r 0.34, P.001), the number of embryos (r 0.27, P.05), the number of ampules of gonadotropins used (r 0.19, P.05), and the number of days of stimulation (r 0.27, P.01). The EMT hcg significantly correlated with age (r 0.26, P.05), the level of estradiol on day of hcg administration (r 0.28, P.001), and the number of oocytes (r 0.26, P.05). Univariate analyses were completed comparing the change in endometrial thickness to the demographics; prestimulation and stimulation parameters were also performed. The EMT Day 6 Baseline significantly correlated with age (r 0.27, P.05), the total ovarian volume (r.30, P.05), the total number of antral follicles (r.35, P.001), the level of estradiol on day 6 of gonadotropin stimulation (r 0.40, P.001), the level of estradiol on day of hcg administration (r 0.37, P.001), the number of oocytes (r 0.32, P.001), the number of embryos (r 0.23, P.05), the number of ampules of gonadotropins used (r 0.22, P.05), and the number of days of stimulation (r 0.29, P.05). The EMT hcg - Day 6 significantly correlated with the level of FSH on day 3 (r 0.23, P.05), the total ovarian volume (r 0.21, P.05), the total number of antral follicles (r 0.28, P.05), the level of estradiol on day 6 of gonadotropin stimulation (r 0.34, P.001), the level of estradiol on day of hcg administration (r 0.27, P.05), and the number of embryos (r 0.20, P.05). The EMT hcg Baseline significantly correlated with age (r 0.20, P.05), the level of estradiol on day of hcg administration (r 0.19, P.05), and the number of oocytes (r 0.23, P.05). Threshold levels for EMT Baseline, EMT Day 6 and EMT hcg as well as the changes in thickness ( EMT Day 6 Baseline, EMT hcg Baseline, EMT hcg - Day 6 ) during the course of an IVF cycle were evaluated using contingency table analysis and ROC curves (Figs. 1 and 2). Table 4 shows the area under the ROC curves with 95% confidence intervals for implantation and pregnancy rates. An EMT Baseline of 3 mm was found to have a significantly higher implantation rate (35.4%) than an EMT Baseline of 3 mm (23.9%) (P.05, RR 1.48 [1.03, 2.12]). No significant threshold level was found for pregnancy rate or pregnancy loss rate. An EMT Day 6 of 6 mm was found to have a significantly lower implantation rate (17.1% vs. 33.3%) (P.001, RR 0.51 [0.34, 0.77]) and pregnancy rate (38.0% vs. 64.5%) (P.01, RR 0.59 [0.40, 0.87]) compared to an EMT Day 6 of 6 mm. No significant threshold level was found for pregnancy loss rate. An EMT hcg of 7 mm was found to have a significantly lower implantation rate (11.9% vs. 28.6%) (P.01, RR Fertility and Sterility 77
5 FIGURE 1 Receiver operator characteristic curves for implantation rates of patients undergoing IVF based on the endometrial lining thickness (EMT) and the change in EMT ( EMT) during the stimulation cycle. Endometrial measurements were taken at baseline before gonadotropin stimulation (EMT Baseline ), on day 6 of gonadotropin stimulation (EMT Day 6 ), and on the day of hcg administration (EMT hcg ). Calculations were also made based on the change in endometrial thickness from the EMT Baseline to EMT Day 6 ( EMT Day 6 Baseline ), the change in endometrial thickness from the EMT Day 6 to EMT hcg ( EMT hcg Day 6 ), and the change in endometrial thickness from the EMT Baseline to EMT hcg ( EMT hcg Baseline ). The most significant measurements as determined by the area under the curve were the EMT Day 6 and the EMT Day 6 Baseline [0.20, 0.85]) compared to an EMT hcg of 7 mm. An EMT hcg of 8 mm was found to have a significantly lower pregnancy rate (34.1% vs. 60.7%) (P.01, RR 0.56 [0.36, 0.89]) compared to an EMT hcg of 8 mm. Of note, only 1 of 24 (4.2%) transferred embryos implanted and only 1 of 8 (12.5%) patients got pregnant with an EMT hcg of 6 mm. No significant threshold level was found for pregnancy loss rate. A EMT Day 6 Baseline 3 mm was found to have a significantly lower implantation rate (22.4% vs. 35.7%) (P.01, RR 0.63 [0.44, 0.88]) compared to a EMT Day 6 Baseline of 3 mm. A EMT Day 6 Baseline of 2 mm was found to have a significantly lower pregnancy rate (42.0% vs. 62.7%) (P.05, RR 0.67 [0.46, 0.97]) compared to a EMT Day 6 Baseline of 2 mm. No significant threshold level was found for pregnancy loss rate. A EMT hcg Day 6 of 0 mm was found to have a significantly higher implantation rate (43.2% vs. 24.8%) (P.05, RR 1.75 [1.15, 2.65]) and pregnancy rate (70.4% vs. 48.5%) (P.05, RR 1.45 [1.06, 2.00]) compared to a EMT hcg Day 6 of 0 mm. No significant threshold level was found for pregnancy loss rate. A EMT hcg Baseline of 3 mm was found to have a significantly lower implantation rate (13.3% vs. 29.7%) (P.01, RR 0.45 [0.25, 0.82]) and pregnancy rate (24.0% vs. 59.4%) (P.01, RR 0.40 [0.20, 0.83]) compared to a EMT hcg Baseline of 3 mm. No significant threshold level was found for pregnancy loss rate. DISCUSSION Previous literature has noted conflicting results regarding the prognostic ability of endometrial thickness on the day of hcg administration (6, 11 16). In reviewing our data, correlations were seen from which general principles can be derived. The endometrial thickness on day 6 of stimulation, EMT Day 6, and the change in the initial endometrial thickness from the baseline appointment to day 6 of stimulation, EMT Day 6 Baseline, seemed to have the most significant association with IVF stimulation and pregnancy outcomes. 78 McWilliams and Frattarelli Endometrial thickness and IVF success Vol. 88, No. 1, July 2007
6 FIGURE 2 Receiver operator characteristic curves for pregnancy rates of patients undergoing IVF based on the endometrial lining thickness (EMT) and the change in EMT ( EMT) during the stimulation cycle. Endometrial measurements were taken at baseline before gonadotropin stimulation (EMT Baseline ), on day 6 of gonadotropin stimulation (EMT Day 6 ), and on the day of hcg administration (EMT hcg ). Calculations were also made based on the change in endometrial thickness from the EMT Baseline to EMT Day 6 ( EMT Day 6 Baseline ), the change in endometrial thickness from the EMT Day 6 to EMT hcg ( EMT hcg - Day 6 ), and the change in endometrial thickness from the EMT Baseline to EMT hcg ( EMT hcg - Baseline ). The most significant measurements as determined by the area under the curve were the EMT Day 6 and the EMT Day 6 Baseline. This significance was confirmed using contingency table analysis and ROC curves. Using contingency tables and ROC curves, we have shown that implantation rates were higher if the EMT was 3 mm for EMT Baseline, 6 mm for EMT Day 6, 7 mm for EMT hcg, 3 mmfor EMT Day 6 Baseline, 0 mmfor EMT hcg Day 6, and 3 mm for EMT hcg Baseline. Likewise, pregnancy rates were higher if the following EMT values were noted: 6 mm for EMT Day 6, 8 mmfor EMT hcg, 2 mm for EMT Day 6 Baseline, 0 mm for EMT hcg Day 6, and 3 mmfor EMT hcg Baseline. Based on these data, if the EMT is less than the threshold, or if the endometrial thickness decreases during the stimulation cycle, the implantation and pregnancy rates decrease dramatically. An EMT hcg of 7 mm was found to have a significantly lower implantation rate (11.9% vs. 28.6%) (P.01, RR 0.42 [0.20, 0.85]) compared to an EMT hcg of 7 mm. An EMT hcg of 8 mm was found to have a significantly lower pregnancy rate (34.1% vs. 60.7%) (P.01, RR 0.56 [0.36, 0.89]) compared to an EMT hcg of 8 mm. Of note, only 1 of 24 (4.2%) transferred embryos implanted and only 1 of 8 (12.5%) patients got pregnant with an EMT hcg of 6 mm. The clinical significance concerning endometrial thickness 6 mmon day 6 or 8 mm on day hcg is unknown. The exact pathophysiology for endometrial receptivity is still unknown. In a previous manuscript, we showed that using Fertility and Sterility 79
7 TABLE 4 Area under the curve and 95% confidence intervals for implantation and pregnancy rates. Implantation rate Pregnancy rate EMT Baseline 0.37 (0.20, 0.53) 0.53 (0.43, 0.61) EMT Day (0.47, 0.72) 0.67 (0.58, 0.77) EMT hcg 0.48 (0.31, 0.65) 0.63 (0.54, 0.73) EMT Day 6 Baseline 0.65 (0.51, 0.78) 0.64 (0.54, 0.74) EMT hcg Day (0.40, 0.72) 0.60 (0.50, 0.71) EMT hcg Baseline 0.41 (0.24, 0.57) 0.46 (0.36, 0.56) adjuvant therapy in patients with thin endometrial linings did not improve outcomes (17). The endometrial thickness on the day of hcg administration, EMT hcg, is often used to document adequate endometrial development. The pregnancy rate threshold for EMT hcg calculated in this study was 8 mm; this is consistent with the findings of Basir et al. (4), who developed an ROC curve looking for a threshold on day of hcg. Both Basir et al. (4) and our study agree that IVF patients with a EMT hcg 8 mm have a statistically significant increased pregnancy rate (4). EMT hcg correlated with the estradiol concentration on the day of hcg, the number of oocytes, and was inversely correlated with age. Based on ROC curves, EMT hcg was less predictive than EMT Day 6 and EMT Day 6 Baseline.In contrast to our design, other studies that have evaluated EMT hcg measurements have used arbitrary threshold values (5, 10, 12, 13, 15). Another difference between our study and other studies includes the timing of the EMT evaluation. Studies have evaluated the endometrial lining on the day before hcg administration (6, 8, 11), the day of hcg administration (4 6, 9, 11 13, 15), the day after hcg administration (8, 10), the day of oocyte retrieval (9, 11, 16), and the day of embryo transfer (7, 11, 14). We could find only two studies, which produced conflicting results, that evaluated the change in endometrial thickness occurring at different points in the IVF cycle (8, 11). Bassil et al. (8) prospectively evaluated the change in endometrial growth from day 10 to day after hcg administration and found that a statistically significant increase in endometrial thickness correlated with a patient s ability to conceive. Noyes et al. (11) found no correlation between pregnancy rates and the endometrial thickness at any time during ovarian stimulation; however, their data showed that the largest change occurred in the first seven days of stimulation. In our study, day 6 was used as our first evaluation of EMT after initiation of exogenous gonadotropins. There was no significant difference in baseline endometrial thickness between those who became pregnant and those who did not become pregnant. There was a significant threshold value of 3 mm for implantation rate, but none for pregnancy rate. This finding is important because the initial thickness of the endometrium may not be as important as endometrial responsiveness early in the stimulation process, as evidenced by the significance values for the EMT Day 6 and EMT Day 6 Baseline. Early endometrial evaluation during gonadotropin stimulation seems to be significant in that it shows which patients have responsive endometrium. Data from Basir et al. (4) support the theory that there is a difference in pregnancy rates with respect to how receptive the endometrial lining is towards stimulation. With the statistically significant and clinically significant findings for the EMT Day 6 and EMT Day 6 Baseline values, our data confirm that the early responsiveness of the endometrium is critical for improved pregnancy success. Both EMT Day 6 and EMT Day 6 Baseline were found to correlate with pregnancy outcomes as well as the IVF prestimulation and stimulation parameters of age, ovarian volume, antral follicles, estradiol levels, oocytes, number of embryos, ampules of gonadotropins used, and number of days of stimulation. Etiologies of infertility were not compared against one another with respect to pregnancy outcomes; however, diminished ovarian reserve showed significantly decreased thickness on EMT Day 6, EMT hcg, and with EMT hcg Baseline, as opposed to anovulation, endometriosis, male factor, tubal factor, or unexplained infertility. It is noteworthy that on EMT Day 6, EMT hcg, and EMT hcg Baseline there was also a statistical difference between those patients pregnant and those not pregnant. This difference between diminished ovarian reserve and other infertility etiologies supports previous findings where patients with diminished ovarian reserve have low probability of conception and decreased fecundity (18). Possible weaknesses of this study include its retrospective nature. However, the data were derived from a prospective database. Therefore, there was no chart review and no patients were lost to follow-up. This decreases the possibility of selection and information biases. The use of contingency table analysis and ROC curves to create significant threshold values so as not to use arbitrary cutoff points was a major strength of the study. Likewise, all stimulation cycles, ultrasounds, oocyte retrievals, and embryo transfers were performed by the author (JLF). 80 McWilliams and Frattarelli Endometrial thickness and IVF success Vol. 88, No. 1, July 2007
8 In summary, continued use of transvaginal ultrasound to evaluate endometrial thickness and the change occurring during ovarian stimulation can aid providers in counseling patients and predicting IVF success. Increased endometrial responsiveness seen on day 6 of gonadotropin stimulation compared to the baseline EMT is important to IVF success. An increase in endometrial response seems to prognosticate better IVF success. Endometrial receptivity is still difficult to prognosticate. It is unclear if the improved IVF success is because of a more responsive or sensitive endometrial lining or if the responsiveness of the endometrial lining is only a marker of better gonadotropin stimulation of the ovary with downstream effects on the endometrium. EMT during the early part of the IVF cycle seems to be a more important prognostic variable than does EMT at the start or end of the IVF cycle. Measuring the EMT earlier or looking at the initial change in endometrial thickness may be an important factor in stratifying those patients with an optimal response from those with a suboptimal response. REFERENCES 1. Erenus M, Zouves C, Rajamahendran P, Leung S, Fluker M, Gomel V. The effect of embryo quality on subsequent pregnancy rates after in vitro fertilization. Fertil Steril 1991;56: Wittemer C, Bettahar-Lebugle K, Ohl J, Rongieres C, Nisand I, Gerlinger P. Zygote evaluation: an efficient tool for embryo selection. Hum Reprod 2000;15: Yuval Y, Lipitiz S, Dor J, Achiron R. The relationships between endometrial thickness, and blood flow and pregnancy rates in in-vitro fertilization. Hum Reprod 1999;14: Basir GS, O WS, So WW, Ng EH, Ho PC. Evaluation of cycle-to-cycle variation of endometrial responsiveness using transvaginal sonography in women undergoing assisted reproduction. Ultrasound Obstet Gynecol 2002;19: Dickey RP, Olar TT, Curole DN, Taylor SN, Rye PH. Endometrial pattern and thickness associated with pregnancy outcome after assisted reproduction technologies. Hum Reprod 1992;7: De Geyter C, Schmitter M, De Geyter M, Nieschlag E, Holzgreve W, Schneider HP. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril 2000;73: Puerto B, Creus M, Carmona F, Civico S, Vanrell JA, Balasch J. Ultrasonography as a predictor of embryo implantation after in vitro fertilization: a controlled study. Fertil Steril 2003;79: Gonen Y, Casper RF, Jacobson W, Blankier J. Endometrial thickness and growth during ovarian stimulation: a possible predictor of implantation in in vitro fertilization. Fertil Steril 1989;52: Sharara FI, Lim J, McClamrock HD. Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hcg administration. J Assist Reprod Genet 1999;16: Noyes N, Liu HC, Sultan K, Schattman G, Rosenwaks Z. Endometrial thickness appears to be a significant factor in embryo implantation in in-vitro fertilization. Hum Reprod 1995;10: Bassil S. Changes in endometrial thickness, width, length and pattern in predicting pregnancy outcome during ovarian stimulation in in vitro fertilization. Ultrasound Obstet Gynecol 2001;18: Dietterich C, Check JH, Choe JK, Nazari A, Lurie D. Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following in vitro fertilization-embryo transfer. Fertil Steril 2002;77: Rinaldi L, Lisi F, Floccari A, Lisi R, Pepe G, Fishel S. Endometrial thickness as a predictor of pregnancy after in-vitro fertilization but not after intracytoplasmic sperm injection. Hum Reprod 1996;11: Kovacs P, Matyas S, Boda K, Kaali SG. The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod 2003;18: Weissman A, Gotlieb L, Casper RF. The detrimental effect of increased endometrial thickness on implantation and pregnancy rates and outcome in an in vitro fertilization program. Fertil Steril 1999;71: Gonen Y, Casper RF. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fert Embryo Transfer 1990; 7: Frattarelli JL, Miller BT, Scott RT. Adjuvant therapy enhances endometrial receptivity in patients undergoing assisted reproduction. Reprod Biomed Online 2006;12: Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT Jr. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 2001;76: Fertility and Sterility 81
IN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 82, NO. 4, OCTOBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION Prognostic
More informationThe effect of endometrial thickness on IVF/ICSI outcome
Human Reproduction Vol.18, No.11 pp. 2337±2341, 2003 DOI: 10.1093/humrep/deg461 The effect of endometrial thickness on IVF/ICSI outcome P.Kovacs 1,3, Sz.Matyas 1, K.Boda 2 and S.G.Kaali 1 1 Kaali Institute
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationIncreased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization embryo transfer
Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization embryo transfer Xingqi Zhang, Ph.D., a Chi-Huang Chen, M.D., b Edmond
More informationOriginal Article. KEY WORDS: Doppler, endometrial thickness, in-vitro fertilization
Original Article Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hcg by 2D Doppler in in-vitro fertilization cycles: A prospective clinical study from a
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationPredicting factors for endometrial thickness during treatment with assisted reproductive technology
Predicting factors for endometrial thickness during treatment with assisted reproductive technology Wiser Amir, M.D., a Baum Micha, M.D., a Hourwitz Ariel, M.D., a Lerner-Geva Liat, M.D., Ph.D., b Dor
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationEvaluation of basal estradiol levels in assisted reproductive technology cycles
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Evaluation of basal
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More information(BMI)=18.0~24.9 kg/m 2 ;
33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV
More informationMedicine. Wei Yang, MMed, Tao Zhang, MMed, Zhou Li, PhD, Xinling Ren, PhD, Bo Huang, PhD, Guijin Zhu, MMed, Lei Jin, PhD. Observational Study
Observational Study Medicine Combined analysis of endometrial thickness and pattern in predicting clinical outcomes of frozen embryo transfer cycles with morphological good-quality blastocyst A retrospective
More informationObesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation
IN VITRO FERTILIZATION Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation Allison Styne-Gross, M.D., a Karen Elkind-Hirsch, Ph.D., b
More informationPredictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older
Reprod Med Biol (2009) 8:145 149 DOI 10.1007/s12522-009-0023-z ORIGINAL ARTICLE Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older Akihisa
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationA luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates
A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates Micah J. Hill, D.O., a Grant D. E. McWilliams, D.O., b Kathleen A. Miller, B.S., c Richard T. Scott, Jr, M.D.,
More informationOvarian response in three consecutive in vitro fertilization cycles
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in
More informationEstradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success
DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27
More informationThe effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles
FERTILITY AND STERILITY Vol. 65, No.3, March 1996 Copyright t';, 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. The effects of prior gravidity on the outcomes of
More informationORIGINAL ARTICLE ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOME IN IUI CYCLES
ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOME IN IUI CYCLES Asha Verma 1, Rekha Mulchandani 2, Nupur Lauria 3, Kusum Verma 4, Sunita Himani 5 HOW TO CITE THIS ARTICLE: Asha Verma, Rekha Mulchandani, Nupur
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationDSJUOG ABSTRACT INTRODUCTION /jp-journals
Firoozeh Ahmadi et al ORIGINAL ARTICLE 10.5005/jp-journals-10009-1491 A Two-year Cross-sectional Prospective Study for Assessment of Endometrial Thickness and Volume using Three-dimensional Transvaginal
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationOriginal Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2
Original Article Comparison of Letrozole and Clomiphene Citrate Efficacy along with Gonadotrophins in Controlled Ovarian Hyperstimulation for Intrauterine Insemination Cycles Fauzia HaqNawaz 1*, Saadia
More informationEvaluation of cycle-to-cycle variation of endometrial. responsiveness using transvaginal sonography in women undergoing assisted reproduction
Ultrasound Obstet Gynecol 2002; 19: 484 489 Evaluation of cycle-to-cycle variation of endometrial Blackwell Science, Ltd responsiveness using transvaginal sonography in women undergoing assisted reproduction
More informationPrognosticating ovarian reserve by the new ovarian response prediction index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationin vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationN.A.Bersinger 1, A.Brandenberger, E.Berger, C.K.Baumann and M.H.Birkhäuser
Human Reproduction vol.13 no.7 pp.1962 1967, 1998 Serum pregnancy-specific β 1 -glycoprotein before embryo transfer is related to endometrial thickness and to outcome prognosis in women undergoing in-vitro
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationInfertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF
Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility
More informationOriginal Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer
Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and
More informationFactors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2015;42(2):67-71 Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles Ju Hee Park
More informationSerum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Amin KV et al. Int J Reprod Contracept Obstet Gynecol. 2018 Aug;7(8):3194-3198 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20183316
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationHana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang
Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile
More informationKisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation
Original Article Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation Aaida Mumtaz, MBBS. 1#, Aqsa Khalid, MBBS. 1#, Zehra Jamil, M.Phil. 2, Syeda Sadia Fatima, Ph.D.
More informationComparison of NuvaRing and Desogen in IVF cycles with ganirelix acetate
J Obstet Gynecol India Vol. 57, No. 3 : May/June 2007 Pg 234-239 ORIGINAL ARTICLE The Journal of Obstetrics and Gynecology of India Comparison of NuvaRing and Desogen in IVF cycles with ganirelix acetate
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationClinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.
UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationSonographic determination of a possible adverse effect of domiphene citrate on endometrial growth
Human Reproduction vol.5 no.6 pp.670-674, 1990 Sonographic determination of a possible adverse effect of domiphene citrate on endometrial growth Yael Gonen 1 and Robert F.Casper Division of Reproductive
More informationEvaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pillai SM et al. Int J Reprod Contracept Obstet Gynecol. 2017 Aug;6(8):3306-3310 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20173190
More informationNew York Science Journal 2014;7(4)
The Minimal Stimulation Protocol for ICSI: An Alternative Protocol for Ovarian Stimulation Adel Elsayed Ibrahim, MD Assisted Reproductive Unit Azhar University Adel.sayed29@gmail.com Abstract: Background:
More informationInfertility: A Generalist s Perspective
Infertility: A Generalist s Perspective Learning Objectives Fertility and Lifestyle: Patient education Describe the basic infertility workup Basic treatment strategies unexplained Heather Huddleston, MD
More informationOutcome of IVF in DES-Exposed Daughters: Experience in the 90s
CLINICAL ASSISTED REPRODUCTION Outcome of IVF in DES-Exposed Daughters: Experience in the 90s LUBNA PAL,1,4 JAN L. SHIFREN,1 KEITH B. ISAACSON,1 YUCHIAO CHANG,2 MARTHA MAREAN,3 LUCY LEYKIN,1 and THOMAS
More informationAssisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION
( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation
More informationComparison of tamoxifen and clomiphene citrate for induction of ovulation in cases with thin endometrium
Original Article Comparison of tamoxifen and clomiphene citrate for induction of ovulation in cases with thin endometrium Department of Obstetrics and Gynecology, Faculty of Medicine, Suez Canal University
More informationIVF Protocols: Hyper & Hypo-Responders, Implantation
IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient
More informationElena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a
FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Predictive usefulness of cycle
More informationUtility of in vitro fertilization at diagnostic laparoscopy*
FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationA pilot trial of large versus small diameter needles for oocyte retrieval
Kushnir et al. Reproductive Biology and Endocrinology 213, 11:22 RESEARCH A pilot trial of large versus small diameter needles for oocyte retrieval Vitaly A Kushnir 1*, Ann Kim 1, Norbert Gleicher 1,2
More informationMilan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,
FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol
More informationPhases of the Ovarian Cycle
OVARIAN CYCLE An ovary contains many follicles, and each one contains an immature egg called an oocyte. A female is born with as many as 2 million follicles, but the number is reduced to 300,000 to 400,000
More informationObjective: To study the role of sildenafil on the echogenic pattern of endometrium in infertile patients with bad endometrium.
The effect of Sildenafil on endometrial characters in patients with infertility Ali F. Al-Assadi, F.I.C.O.G.,C.A.B.O.G.1. Sajeda A. Al-Rubaye, F.I.C.O.G.1 Zainab Laaiby, M.B.Ch.B.2 (1- Assist. Prof./Basra
More informationIVF treatment should not be postponed for patients with high basal FSH concentrations
Reproductive BioMedicine Online (2010) 21, 631 635 www.sciencedirect.com www.rbmonline.com SHORT COMMUNICATION IVF treatment should not be postponed for patients with high basal FSH concentrations Ettie
More informationCOMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL
COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationDuration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial
Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial Christine S. Goudge, M.D., Theodore C. Nagel, M.D., and Mark A. Damario, M.D. Division
More informationBest practices of ASRM and ESHRE
Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction
More informationDepartment of Gynaecology and Reproductive Medicine, University Hospital, University of Western Ontario, London, Ontario, Canada
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationOvarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy
Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human
More informationCarole Dietterich, R.T., R.D.M.S., Jerome H. Check, M.D., Ph.D., Jung K. Choe, M.D., Ahmad Nazari, M.D., and Deborah Lurie, Ph.D.
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Increased endometrial
More informationThe study of correlation between BMI and infertility. Dr. seyed mohammadreza fouladi
The study of correlation between BMI and infertility Dr. seyed mohammadreza fouladi Female Infertility Infertility is a generally defined as one year unprotected intercourse without contraception. Approximately
More informationDoes a woman s educational attainment influence in vitro fertilization outcomes?
Does a woman s educational attainment influence in vitro fertilization outcomes? The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
More informationEndometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration
Wu et al. Reproductive Biology and Endocrinology 2014, 12:96 RESEARCH Open Access Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH
More informationAnalyzing the risk factors for a diminished oocyte retrieval rate under controlled ovarian stimulation
Received: 5 January 2016 Accepted: 16 May 2016 DOI: 10.1002/rmb2.12004 ORIGINAL ARTICLE Analyzing the risk factors for a diminished oocyte retrieval rate under controlled ovarian stimulation Mayumi Nakamura
More informationOptimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE
Optimizing Fertility and Wellness After Cancer Kat Lin, MD, MSCE University Reproductive Care University of Washington Nov. 6, 2010 Optimism in Numbers 5-year survival rate 78% for all childhood cancers
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationOvarian stimulation and inflammation, not always friends! Marc-André Sirard DVM PhD, Canadian Research Chair in Reproduction Genomics
Ovarian stimulation and inflammation, not always friends! Marc-André Sirard DVM PhD, Canadian Research Chair in Reproduction Genomics Conflict of interest Controlled Ovarian Stimulation Timing Test (COST2)GFI
More informationUnderstanding Infertility, Evaluations, and Treatment Options
Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Human Ovarian Steroidogenesis and Gonadotrophin Stimulation Johan
More informationBlastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2 3 embryo transfer cycles: a prospective, randomized study
FERTILITY AND STERILITY VOL. 81, NO. 3, MARCH 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastocyst-stage embryo transfer
More informationAnti-Mullerian hormone (AMH) as predictor of ovarian reserve
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Shembekar CA et al. Int J Reprod Contracept Obstet Gynecol. 2017 Sep;6(9):4006-4010 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174053
More informationPrediction modeling for live birth in in vitro fertilization. Kristen E. Gray. A dissertation. submitted in partial fulfillment of the
Prediction modeling for live birth in in vitro fertilization Kristen E. Gray A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington
More informationUterus & Ovary 2015; 2: e904. doi: /uo.904; 2015 by Ahmed M Maged, et al.
RESEARCH ARTICLE Phytoestrogens as an alternative to estradiol in reversing the antiestrogenic effect of clomid on endometrium in ovulation induction in cases of polycystic ovarian syndrome (PCOS) Ahmed
More informationPrognostic value of day 3 estradiol on in vitro fertilization outcome*
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization
More informationVanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol
More informationManish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group
Manish Banker Nova IVI Fertility Pulse Women's Hospital Gujarat, India Declared receipt of grants; member of a company advisory board, board of director or similar group The Indian point of view Manish
More informationSample size a Main finding b Main limitations
1 Table 1. Available studies on the relation between endometriosis and miscarriage (1995-2015). Study (citation) Country Study period Study design Sample size a Main finding b Main limitations Matoras
More informationOvarian age-based stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization
Ovarian age-based stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization Norbert Gleicher, M.D., and David Barad, M.D. Center for Human
More informationRafael A. Cabrera, M.D., Laurel Stadtmauer, M.D., Ph.D., Jacob F. Mayer, Ph.D., William E. Gibbons, M.D., and Sergio Oehninger, M.D., Ph.D.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant
More informationInfertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations
Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should
More informationAntral follicle count in clinical practice: analyzing clinical relevance
CONTROVERSY I Antral follicle count in clinical practice: analyzing clinical relevance Albert Hsu, M.D., Margaret Arny, Ph.D., Alexander B. Knee, M.S., Carrie Bell, M.D., Elizabeth Cook, Ph.D., Amy L.
More informationThe Significance of Low Anti-Müllerian Hormone Levels in Young Women Undergoing in Vitro Fertilization
The Significance of Low Anti-Müllerian Hormone Levels in Young Women Undergoing in Vitro Fertilization Caitlin Haswell, M.D., Estil Strawn, Jr., M.D., Aniko Szabo, Ph.D., Joseph Davis, D.O., and Kate D.
More informationThe Human Menstrual Cycle
The Human Menstrual Cycle Name: The female human s menstrual cycle is broken into two phases: the Follicular Phase and the Luteal Phase. These two phases are separated by an event called ovulation. (1)
More information2013 Sep.; 24(3):
Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2013.03.0151 2013 Sep.; 24(3):151-158 E-mail: randc_journal@163.com Reducing the Trigger Dose of Human Chorionic Gonadotrophin Does
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationIvf day 6 estradiol level
Ivf day 6 estradiol level Search It is also important to measure the estradiol on day 3. Day 2 is fine. The reason its day 3 is 15-20 years ago, the IVF medications were always started on day 3. Day 3
More informationN. Shirazian, MD. Endocrinologist
N. Shirazian, MD Internist, Endocrinologist Inside the ovary Day 15-28: empty pyfollicle turns into corpus luteum (yellow body) Immature eggs Day 1-13: 13: egg developing inside the growing follicle Day
More informationRecent Developments in Infertility Treatment
Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other
More informationThe association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age
Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationArticle Evaluation of functional ovarian reserve in 60 patients
RBMOnline - Vol 7. No 2. 200 204 Reproductive BioMedicine Online; www.rbmonline.com/article/846 on web 12 June 2003 Article Evaluation of functional ovarian reserve in 60 patients Dr Giuseppe Loverro Giuseppe
More information